Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Discover high-quality research tools to investigate GLP-1 mechanisms and next-generation metabolic targets.
OBESITY RESEARCH SOLUTIONSVanillic acid is a phenol that has been found in A. sinensis and has diverse biological activities.1,2,3,4 It inhibits biofilm formation by carbapenem-resistant E. hormaechei (CREH; MIC = 0.8 mg/ml).1 Vanillic acid (12 µg/ml) inhibits cell death induced by the antitumor agent doxorubicin (Item No. 15007) in H9c2 rat cardiomyocytes.2 In vivo, vanillic acid (10, 20, and 40 mg/kg per day) reduces cardiac levels of lactate dehydrogenase, cardiac troponin-1, and malondialdehyde (MDA) in a rat model of doxorubicin-induced cardiotoxicity. It reduces hyperglycemia and renal levels of thiobarbituric acid reactive substances (TBARS), TNF-α, and NF-κB, as well as attenuates impaired renal function in a rat model of diabetes induced by streptozotocin (STZ; Item No. 13104) and nicotinamide (Item No. 11127).3 Vanillic acid (25 and 50 mg/kg) also reduces bronchoalveolar lavage fluid (BALF) inflammatory cell infiltration and airway inflammation in a rat model of ovalbumin-induced asthma.4
WARNING This product is not for human or veterinary use.
1. Antibacterial mechanism of vanillic acid on physiological, morphological, and biofilm properties of carbapenem-
2. Cardioprotective potential of vanillic acid. Clin. Exp. Pharmacol. Physiol. 50(3), 193-204 (2023).
3. Protective effect of vanillic acid against diabetes and diabetic nephropathy by attenuating oxidative stress and upregulation of NF-
4. Vanillic acid mitigates the ovalbumin (OVA)-